Navigation Links
ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
Date:6/18/2012

SAN DIEGO, June 18, 2012 /PRNewswire/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the Company has been invited to participate in and present at the BIO Business Forum at the 2012 BIO International Convention, which is being held June 18 – 21, 2012 in Boston, MA.  Brian M. Culley, Chief Executive Officer of ADVENTRX, will present on Tuesday, June 19th at 9:30 a.m. EDT in the Celtics Room (104C) at the Boston Convention & Exhibition Center.

(Logo: http://photos.prnewswire.com/prnh/20120612/LA22456LOGO-a)

"We look forward to participating in the BIO Business Forum, which will allow us to reach a global audience representing over 60 countries and to take advantage of the significant one-on-one partnering and networking opportunities at the convention," stated Mr. Culley.  "We believe in ANX-188's potential as an effective treatment for patients with sickle cell disease and are pleased to have the opportunity to continue to share its story with industry leaders and potential partners, particularly on June 19th, which is designated by the United Nations as World Sickle Cell Awareness Day." 

About BIO
The Biotechnology Industry Organization (BIO) represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry. The BIO Business Forum® has grown over the past eleven years to become the industry's largest partnering event, hosting a record breaking 21,00
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Michael Cola Joins the Board of Directors of Vanda Pharmaceuticals
2. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
3. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
4. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
5. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
6. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
7. Valeant Pharmaceuticals To Host Investor Day
8. First sales of DIFICLIRâ„¢ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
9. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
10. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instantâ„¢
11. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
(Date:1/15/2014)... The Cadence Fitness & Health Center has been ... Fitness Association, a non-profit organization assisting medically integrated health ... Cadence Fitness & Health Center is the only certified ... the Chicagoland area. "The certification means the ...
Breaking Medicine Technology:Superbugs No Longer Ride In Rescue Vehicles 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
(Date:4/18/2014)... researchers have been awarded two-year grants for their work ... month. Of the 110 initial submissions to the new ... only four projects were funded, three of which are ... M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, ... oncology, will use his $500,000 proof of principle grant ...
(Date:4/18/2014)... Fraser University psychologists have made a brain-related discovery ... attention-deficit disorders. , This discovery opens up the ... or suppress a specific brain activity that the ... , The Journal of Neuroscience has ... John McDonald, an associate professor of psychology and ...
(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
(Date:4/17/2014)... Scientists have identified the first genetic variant specifically ... sub-type accounting for around 10-15 per cent of ... study of the breast cancer sub-type, called invasive ... genetic causes of this particular kind of breast ... The research, published today (Thursday) in the journal ...
(Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2
... ... ultrafiltration, NEW ... today that it will be exhibiting its Dual Stage,Ultrafilter products ... conference in Denver, Colorado, June,15th-19th, 2008. Building on the success ...
... BD (Becton,Dickinson and Company) (NYSE: BDX ), ... present at the Goldman Sachs Twenty-Ninth,Annual Global Healthcare Conference ... The live webcast of BD,s presentation can be accessed ... will be available for replay,through Wednesday, June 18, 2008., ...
... June 3 HLTH Corporation,(Nasdaq: HLTH ) ... definitive,agreement to sell its ViPS segment to General ... Dynamics Corporation,(NYSE: GD ) for $225 million ... conditions, including the expiration or termination of the ...
... can produce tiny magnetic nuggets after the introduction of ... gene MagA could become a valuable tool for tracking ... (MRI), says Xiaoping Hu, PhD, professor of biomedical engineering ... , "We have found a very simple way to ...
... N.Y., June 3 MedAmerica reports 2007 was ... results. In,addition, MedAmerica outperformed the long-term care insurance ... annual sales rate of 10%. (LIMRA 2007), ... Rochester, NY),MedAmerica Insurance Company (Home Office: Pittsburgh, PA), ...
... On June 7, 2008 the Philadelphia,Physicians for Student ... in the Philadelphia School District. Student,athletes in Pennsylvania ... eligible,to compete in interscholastic activities. The standard physicals ... enough to identify some potentially,life-threatening conditions., The ...
Cached Medicine News:Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 2Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 3Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 4Health News:HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million 2Health News:HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million 3Health News:Philly's Top Doc's Organize to Help Prevent Young Athlete Deaths in Philadelphia 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: